Stockreport

The Oncology Institute: Making Progress [Seeking Alpha]

The Oncology Institute, Inc.  (TOI) 
PDF TOI raised FY25 guidance to $500M revenue and expects positive Adj. EBITDA in Q4, with cash flow positivity likely by mid-2026. Despite a massive share price surge in [Read more]